Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6361.5000 -234.00 (-3.55%)

NSE Aug 01, 2025 15:31 PM

37.83% Gain from 52W Low

Volume: 467.2K

Divi's Laboratories Ltd.

10 Nov 2024

6361.50

-3.55%

Divi's Labs (SELL): Healthy Q2; rich valuations

Sell: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

DIVI reported healthy 2QFY25 earnings which was a beat on our estimates. Exports contributed 87% of sales and the US 71%

Divi's Laboratories Ltd. is trading above its 200 day SMA of 6091.3